Search
The collective efforts of the “TeamLabs” will accelerate discoveries in glioblastoma, ovarian, and pancreatic cancers
Two important clinical trials to increase treatment options for mantle cell lymphoma patients are currently recruiting patients.
Learn how MSK doctors deliver intense doses of radiation with great precision using MRI guidance.
What inspires the outstanding young scientists who come from around the world to train at MSK?
Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Learn how MSK researchers are trying to understand how the immune system senses cancer in order to make better immunotherapies.
Read about some of the most important clinical advances made at MSK in 2020.
Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.
Leukemia patients may do better on CAR T cell therapy when they are treated early, before their disease relapses.